Symbolbild · KI-generiert
Vireo Growth Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Vireo Growth Inc. | VREO | CSE | 456 Mio. USD |
| Rezolute, Inc. (NV) | RZLT | NASDAQ | 454 Mio. USD |
| Aquestive Therapeutics, Inc. | AQST | NASDAQ | 464 Mio. USD |
| ClearPoint Neuro, Inc. | CLPT | NASDAQ | 448 Mio. USD |
| ProKidney Corp. | PROK | NASDAQ | 465 Mio. USD |
| Viemed Healthcare, Inc. | VMD | NASDAQ | 447 Mio. USD |
| Q32 Bio Inc. | QTTB | NASDAQ | 467 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.